Results 151 to 160 of about 12,335 (206)

Correction: Research progress of B7-H3 in malignant tumors. [PDF]

Front Immunol
Zhao S, Zhang H, Shang G.
europepmc   +1 more source

B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors. [PDF]

Cancer Metastasis Rev
Jansen L, Wienke J, Molkenbur R, Rossig C, Meissner R.   +4 more
europepmc   +1 more source

B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment. [PDF]

Pathol Oncol Res
Ott JM, Gassenmaier V, Bitzer M, Schürch CM, Heitmann JS, Hagelstein I.   +5 more
europepmc   +1 more source

A novel cytotoxic anti-B7-H3 affibody with therapeutic potential in acute myeloid leukemia. [PDF]

Front Pharmacol
Vasilescu AM, Vasilescu AG, Sima LE, Munteanu CVA, Baran N, Szedlacsek ȘE.   +5 more
europepmc   +1 more source

The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment. [PDF]

Cancers (Basel)
Papavassiliou KA, Sofianidi AA, Papavassiliou AG.   +2 more
europepmc   +1 more source

Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. [PDF]

Biomedicines
Lutskovich DV, Meleshko AN, Stepanova VM, Dormeshkin DO, Rubtsov YP.   +4 more
europepmc   +1 more source

A monoclonal antibody targeting B7-H3 in human embryonic stem cells exhibits anti-tumor activity in hepatocellular carcinoma xenografts. [PDF]

Transl Oncol
Han SH, Seo H, Lee JY, Cheon YJ, Han S, Choi MJ, Lee HM, Kim DS, Choi D, Ryu CJ.   +9 more
europepmc   +1 more source

Three-Dimensional Tumor Spheroids Reveal B7-H3 CAR T Cell Infiltration Dynamics and Microenvironment-Induced Functional Reprogramming in Solid Tumors. [PDF]

Cells
Chen F, Ning K, Xie Y, Yang X, Yu L, Wang X.   +5 more
europepmc   +1 more source

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer. [PDF]

J Exp Clin Cancer Res
Cattaneo G, Ventin M, Arya S, Bailey C, Vantaku VR, Jia J, Qi M, Maggs L, Wang X, Parangi S, Ferrone S, Ferrone CR.   +11 more
europepmc   +1 more source

Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]

Cancer Immunol Immunother
De Maria R, Donini C, Capellero S, Massa A, Galvagno F, Proment A, Vitali L, Vigna E, Landoni E, Dotti G, Leuci V, Accornero P, Conti LC, Olimpo M, Berrino E, Grignani G, Sapino A, Sangiolo D, Aresu L.   +18 more
europepmc   +1 more source